 | • レポートコード：MRC2-11QY03650 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はがん性疼痛治療薬のグローバル市場について調査・分析したレポートです。種類別（オピオイド、非ステロイド性抗炎症薬、その他）市場規模、用途別（パラセタモール治療関連免疫療法、放射線療法、化学療法、ホルモン療法）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別がん性疼痛治療薬の競争状況、市場シェア ・世界のがん性疼痛治療薬市場：種類別市場規模 2015年-2020年（オピオイド、非ステロイド性抗炎症薬、その他） ・世界のがん性疼痛治療薬市場：種類別市場規模予測 2021年-2026年（オピオイド、非ステロイド性抗炎症薬、その他） ・世界のがん性疼痛治療薬市場：用途別市場規模 2015年-2020年（パラセタモール治療関連免疫療法、放射線療法、化学療法、ホルモン療法） ・世界のがん性疼痛治療薬市場：用途別市場規模予測 2021年-2026年（パラセタモール治療関連免疫療法、放射線療法、化学療法、ホルモン療法） ・北米のがん性疼痛治療薬市場分析：米国、カナダ ・ヨーロッパのがん性疼痛治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのがん性疼痛治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のがん性疼痛治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのがん性疼痛治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：BioDelivery Science、ProStrakan Group、Teva pharmaceuticals、Eli-Lilly、Grunenthal Group、GW Pharmaceuticals、Johnson＆Johnson、Meda Pharmaceuticals、Orexo、Sanofi、WEX Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Pain in cancer may come from compressing or infiltrating nearby body parts, from treatments and diagnostic procedures or from skin, nerve, and the other changes caused by a hormone imbalance or immune response.
Factors such as the unmet medical needs of patients drive the market growth during the forecast period. Currently, the drugs that are available for reducing pains associated with cancer have a prolonged duration of action and are characterized by undesirable effects like sedation and respiratory depression. Consequently, this presents an opportunity for the vendors to bring in therapies with fewer side effects and a better efficacy parameter.
Market Analysis and Insights: Global Cancer Pain Therapeutics Market
The global Cancer Pain Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cancer Pain Therapeutics Scope and Market Size
Cancer Pain Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Pain Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Cancer Pain Therapeutics market is segmented into
Opioids
Non-Steroidal Anti-Inflammatory Drugs
Others
Segment by Application, the Cancer Pain Therapeutics market is segmented into
Paracetamol Treatment-Related Immunotherapy
Radiotherapy
Chemotherapy
Hormone Therapy
Regional and Country-level Analysis
The Cancer Pain Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cancer Pain Therapeutics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cancer Pain Therapeutics Market Share Analysis
Cancer Pain Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Pain Therapeutics business, the date to enter into the Cancer Pain Therapeutics market, Cancer Pain Therapeutics product introduction, recent developments, etc.
The major vendors covered:
BioDelivery Science
ProStrakan Group
Teva pharmaceuticals
Eli-Lilly
Grunenthal Group
GW Pharmaceuticals
Johnson＆Johnson
Meda Pharmaceuticals
Orexo
Sanofi
WEX Pharmaceuticals
1 Study Coverage
1.1 Cancer Pain Therapeutics Product Introduction
1.2 Market Segments
1.3 Key Cancer Pain Therapeutics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cancer Pain Therapeutics Market Size Growth Rate by Type
1.4.2 Opioids
1.4.3 Non-Steroidal Anti-Inflammatory Drugs
1.4.4 Others
1.5 Market by Application
1.5.1 Global Cancer Pain Therapeutics Market Size Growth Rate by Application
1.5.2 Paracetamol Treatment-Related Immunotherapy
1.5.3 Radiotherapy
1.5.4 Chemotherapy
1.5.5 Hormone Therapy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cancer Pain Therapeutics Market Size, Estimates and Forecasts
2.1.1 Global Cancer Pain Therapeutics Revenue 2015-2026
2.1.2 Global Cancer Pain Therapeutics Sales 2015-2026
2.2 Global Cancer Pain Therapeutics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Cancer Pain Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Cancer Pain Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Cancer Pain Therapeutics Competitor Landscape by Players
3.1 Cancer Pain Therapeutics Sales by Manufacturers
3.1.1 Cancer Pain Therapeutics Sales by Manufacturers (2015-2020)
3.1.2 Cancer Pain Therapeutics Sales Market Share by Manufacturers (2015-2020)
3.2 Cancer Pain Therapeutics Revenue by Manufacturers
3.2.1 Cancer Pain Therapeutics Revenue by Manufacturers (2015-2020)
3.2.2 Cancer Pain Therapeutics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cancer Pain Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cancer Pain Therapeutics Revenue in 2019
3.2.5 Global Cancer Pain Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Cancer Pain Therapeutics Price by Manufacturers
3.4 Cancer Pain Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Cancer Pain Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Pain Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Pain Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cancer Pain Therapeutics Market Size by Type (2015-2020)
4.1.1 Global Cancer Pain Therapeutics Sales by Type (2015-2020)
4.1.2 Global Cancer Pain Therapeutics Revenue by Type (2015-2020)
4.1.3 Cancer Pain Therapeutics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cancer Pain Therapeutics Market Size Forecast by Type (2021-2026)
4.2.1 Global Cancer Pain Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Cancer Pain Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Cancer Pain Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cancer Pain Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cancer Pain Therapeutics Market Size by Application (2015-2020)
5.1.1 Global Cancer Pain Therapeutics Sales by Application (2015-2020)
5.1.2 Global Cancer Pain Therapeutics Revenue by Application (2015-2020)
5.1.3 Cancer Pain Therapeutics Price by Application (2015-2020)
5.2 Cancer Pain Therapeutics Market Size Forecast by Application (2021-2026)
5.2.1 Global Cancer Pain Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Cancer Pain Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Cancer Pain Therapeutics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Cancer Pain Therapeutics by Country
6.1.1 North America Cancer Pain Therapeutics Sales by Country
6.1.2 North America Cancer Pain Therapeutics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Cancer Pain Therapeutics Market Facts & Figures by Type
6.3 North America Cancer Pain Therapeutics Market Facts & Figures by Application
7 Europe
7.1 Europe Cancer Pain Therapeutics by Country
7.1.1 Europe Cancer Pain Therapeutics Sales by Country
7.1.2 Europe Cancer Pain Therapeutics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cancer Pain Therapeutics Market Facts & Figures by Type
7.3 Europe Cancer Pain Therapeutics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Cancer Pain Therapeutics by Region
8.1.1 Asia Pacific Cancer Pain Therapeutics Sales by Region
8.1.2 Asia Pacific Cancer Pain Therapeutics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Cancer Pain Therapeutics Market Facts & Figures by Type
8.3 Asia Pacific Cancer Pain Therapeutics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Cancer Pain Therapeutics by Country
9.1.1 Latin America Cancer Pain Therapeutics Sales by Country
9.1.2 Latin America Cancer Pain Therapeutics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Cancer Pain Therapeutics Market Facts & Figures by Type
9.3 Central & South America Cancer Pain Therapeutics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Cancer Pain Therapeutics by Country
10.1.1 Middle East and Africa Cancer Pain Therapeutics Sales by Country
10.1.2 Middle East and Africa Cancer Pain Therapeutics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Cancer Pain Therapeutics Market Facts & Figures by Type
10.3 Middle East and Africa Cancer Pain Therapeutics Market Facts & Figures by Application
11 Company Profiles
11.1 BioDelivery Science
11.1.1 BioDelivery Science Corporation Information
11.1.2 BioDelivery Science Description and Business Overview
11.1.3 BioDelivery Science Sales, Revenue and Gross Margin (2015-2020)
11.1.4 BioDelivery Science Cancer Pain Therapeutics Products Offered
11.1.5 BioDelivery Science Related Developments
11.2 ProStrakan Group
11.2.1 ProStrakan Group Corporation Information
11.2.2 ProStrakan Group Description and Business Overview
11.2.3 ProStrakan Group Sales, Revenue and Gross Margin (2015-2020)
11.2.4 ProStrakan Group Cancer Pain Therapeutics Products Offered
11.2.5 ProStrakan Group Related Developments
11.3 Teva pharmaceuticals
11.3.1 Teva pharmaceuticals Corporation Information
11.3.2 Teva pharmaceuticals Description and Business Overview
11.3.3 Teva pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Teva pharmaceuticals Cancer Pain Therapeutics Products Offered
11.3.5 Teva pharmaceuticals Related Developments
11.4 Eli-Lilly
11.4.1 Eli-Lilly Corporation Information
11.4.2 Eli-Lilly Description and Business Overview
11.4.3 Eli-Lilly Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eli-Lilly Cancer Pain Therapeutics Products Offered
11.4.5 Eli-Lilly Related Developments
11.5 Grunenthal Group
11.5.1 Grunenthal Group Corporation Information
11.5.2 Grunenthal Group Description and Business Overview
11.5.3 Grunenthal Group Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Grunenthal Group Cancer Pain Therapeutics Products Offered
11.5.5 Grunenthal Group Related Developments
11.6 GW Pharmaceuticals
11.6.1 GW Pharmaceuticals Corporation Information
11.6.2 GW Pharmaceuticals Description and Business Overview
11.6.3 GW Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GW Pharmaceuticals Cancer Pain Therapeutics Products Offered
11.6.5 GW Pharmaceuticals Related Developments
11.7 Johnson＆Johnson
11.7.1 Johnson＆Johnson Corporation Information
11.7.2 Johnson＆Johnson Description and Business Overview
11.7.3 Johnson＆Johnson Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Johnson＆Johnson Cancer Pain Therapeutics Products Offered
11.7.5 Johnson＆Johnson Related Developments
11.8 Meda Pharmaceuticals
11.8.1 Meda Pharmaceuticals Corporation Information
11.8.2 Meda Pharmaceuticals Description and Business Overview
11.8.3 Meda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Meda Pharmaceuticals Cancer Pain Therapeutics Products Offered
11.8.5 Meda Pharmaceuticals Related Developments
11.9 Orexo
11.9.1 Orexo Corporation Information
11.9.2 Orexo Description and Business Overview
11.9.3 Orexo Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Orexo Cancer Pain Therapeutics Products Offered
11.9.5 Orexo Related Developments
11.10 Sanofi
11.10.1 Sanofi Corporation Information
11.10.2 Sanofi Description and Business Overview
11.10.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sanofi Cancer Pain Therapeutics Products Offered
11.10.5 Sanofi Related Developments
11.1 BioDelivery Science
11.1.1 BioDelivery Science Corporation Information
11.1.2 BioDelivery Science Description and Business Overview
11.1.3 BioDelivery Science Sales, Revenue and Gross Margin (2015-2020)
11.1.4 BioDelivery Science Cancer Pain Therapeutics Products Offered
11.1.5 BioDelivery Science Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Cancer Pain Therapeutics Market Estimates and Projections by Region
12.1.1 Global Cancer Pain Therapeutics Sales Forecast by Regions 2021-2026
12.1.2 Global Cancer Pain Therapeutics Revenue Forecast by Regions 2021-2026
12.2 North America Cancer Pain Therapeutics Market Size Forecast (2021-2026)
12.2.1 North America: Cancer Pain Therapeutics Sales Forecast (2021-2026)
12.2.2 North America: Cancer Pain Therapeutics Revenue Forecast (2021-2026)
12.2.3 North America: Cancer Pain Therapeutics Market Size Forecast by Country (2021-2026)
12.3 Europe Cancer Pain Therapeutics Market Size Forecast (2021-2026)
12.3.1 Europe: Cancer Pain Therapeutics Sales Forecast (2021-2026)
12.3.2 Europe: Cancer Pain Therapeutics Revenue Forecast (2021-2026)
12.3.3 Europe: Cancer Pain Therapeutics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Cancer Pain Therapeutics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Cancer Pain Therapeutics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Cancer Pain Therapeutics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Cancer Pain Therapeutics Market Size Forecast by Region (2021-2026)
12.5 Latin America Cancer Pain Therapeutics Market Size Forecast (2021-2026)
12.5.1 Latin America: Cancer Pain Therapeutics Sales Forecast (2021-2026)
12.5.2 Latin America: Cancer Pain Therapeutics Revenue Forecast (2021-2026)
12.5.3 Latin America: Cancer Pain Therapeutics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Cancer Pain Therapeutics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Cancer Pain Therapeutics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Cancer Pain Therapeutics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Cancer Pain Therapeutics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Cancer Pain Therapeutics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Pain Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Cancer Pain Therapeutics Market Segments
Table 2. Ranking of Global Top Cancer Pain Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cancer Pain Therapeutics Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Opioids
Table 5. Major Manufacturers of Non-Steroidal Anti-Inflammatory Drugs
Table 6. Major Manufacturers of Others
Table 7. Global Cancer Pain Therapeutics Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Cancer Pain Therapeutics Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Cancer Pain Therapeutics Sales by Regions 2015-2020 (K Units)
Table 10. Global Cancer Pain Therapeutics Sales Market Share by Regions (2015-2020)
Table 11. Global Cancer Pain Therapeutics Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Cancer Pain Therapeutics Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Cancer Pain Therapeutics Sales Share by Manufacturers (2015-2020)
Table 14. Global Cancer Pain Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Cancer Pain Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Pain Therapeutics as of 2019)
Table 16. Cancer Pain Therapeutics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Cancer Pain Therapeutics Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Cancer Pain Therapeutics Price (2015-2020) (USD/Unit)
Table 19. Cancer Pain Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Cancer Pain Therapeutics Product Type
Table 21. Date of International Manufacturers Enter into Cancer Pain Therapeutics Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Pain Therapeutics Sales by Type (2015-2020) (K Units)
Table 24. Global Cancer Pain Therapeutics Sales Share by Type (2015-2020)
Table 25. Global Cancer Pain Therapeutics Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Cancer Pain Therapeutics Revenue Share by Type (2015-2020)
Table 27. Cancer Pain Therapeutics Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Cancer Pain Therapeutics Sales by Application (2015-2020) (K Units)
Table 29. Global Cancer Pain Therapeutics Sales Share by Application (2015-2020)
Table 30. North America Cancer Pain Therapeutics Sales by Country (2015-2020) (K Units)
Table 31. North America Cancer Pain Therapeutics Sales Market Share by Country (2015-2020)
Table 32. North America Cancer Pain Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Cancer Pain Therapeutics Revenue Market Share by Country (2015-2020)
Table 34. North America Cancer Pain Therapeutics Sales by Type (2015-2020) (K Units)
Table 35. North America Cancer Pain Therapeutics Sales Market Share by Type (2015-2020)
Table 36. North America Cancer Pain Therapeutics Sales by Application (2015-2020) (K Units)
Table 37. North America Cancer Pain Therapeutics Sales Market Share by Application (2015-2020)
Table 38. Europe Cancer Pain Therapeutics Sales by Country (2015-2020) (K Units)
Table 39. Europe Cancer Pain Therapeutics Sales Market Share by Country (2015-2020)
Table 40. Europe Cancer Pain Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Cancer Pain Therapeutics Revenue Market Share by Country (2015-2020)
Table 42. Europe Cancer Pain Therapeutics Sales by Type (2015-2020) (K Units)
Table 43. Europe Cancer Pain Therapeutics Sales Market Share by Type (2015-2020)
Table 44. Europe Cancer Pain Therapeutics Sales by Application (2015-2020) (K Units)
Table 45. Europe Cancer Pain Therapeutics Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Cancer Pain Therapeutics Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Cancer Pain Therapeutics Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Cancer Pain Therapeutics Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Cancer Pain Therapeutics Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Cancer Pain Therapeutics Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Cancer Pain Therapeutics Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Cancer Pain Therapeutics Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Cancer Pain Therapeutics Sales Market Share by Application (2015-2020)
Table 54. Latin America Cancer Pain Therapeutics Sales by Country (2015-2020) (K Units)
Table 55. Latin America Cancer Pain Therapeutics Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Cancer Pain Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Cancer Pain Therapeutics Revenue Market Share by Country (2015-2020)
Table 58. Latin America Cancer Pain Therapeutics Sales by Type (2015-2020) (K Units)
Table 59. Latin America Cancer Pain Therapeutics Sales Market Share by Type (2015-2020)
Table 60. Latin America Cancer Pain Therapeutics Sales by Application (2015-2020) (K Units)
Table 61. Latin America Cancer Pain Therapeutics Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Cancer Pain Therapeutics Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Cancer Pain Therapeutics Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Cancer Pain Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Cancer Pain Therapeutics Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Cancer Pain Therapeutics Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Cancer Pain Therapeutics Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Cancer Pain Therapeutics Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Cancer Pain Therapeutics Sales Market Share by Application (2015-2020)
Table 70. BioDelivery Science Corporation Information
Table 71. BioDelivery Science Description and Major Businesses
Table 72. BioDelivery Science Cancer Pain Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. BioDelivery Science Product
Table 74. BioDelivery Science Recent Development
Table 75. ProStrakan Group Corporation Information
Table 76. ProStrakan Group Description and Major Businesses
Table 77. ProStrakan Group Cancer Pain Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. ProStrakan Group Product
Table 79. ProStrakan Group Recent Development
Table 80. Teva pharmaceuticals Corporation Information
Table 81. Teva pharmaceuticals Description and Major Businesses
Table 82. Teva pharmaceuticals Cancer Pain Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Teva pharmaceuticals Product
Table 84. Teva pharmaceuticals Recent Development
Table 85. Eli-Lilly Corporation Information
Table 86. Eli-Lilly Description and Major Businesses
Table 87. Eli-Lilly Cancer Pain Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Eli-Lilly Product
Table 89. Eli-Lilly Recent Development
Table 90. Grunenthal Group Corporation Information
Table 91. Grunenthal Group Description and Major Businesses
Table 92. Grunenthal Group Cancer Pain Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Grunenthal Group Product
Table 94. Grunenthal Group Recent Development
Table 95. GW Pharmaceuticals Corporation Information
Table 96. GW Pharmaceuticals Description and Major Businesses
Table 97. GW Pharmaceuticals Cancer Pain Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. GW Pharmaceuticals Product
Table 99. GW Pharmaceuticals Recent Development
Table 100. Johnson＆Johnson Corporation Information
Table 101. Johnson＆Johnson Description and Major Businesses
Table 102. Johnson＆Johnson Cancer Pain Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Johnson＆Johnson Product
Table 104. Johnson＆Johnson Recent Development
Table 105. Meda Pharmaceuticals Corporation Information
Table 106. Meda Pharmaceuticals Description and Major Businesses
Table 107. Meda Pharmaceuticals Cancer Pain Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Meda Pharmaceuticals Product
Table 109. Meda Pharmaceuticals Recent Development
Table 110. Orexo Corporation Information
Table 111. Orexo Description and Major Businesses
Table 112. Orexo Cancer Pain Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Orexo Product
Table 114. Orexo Recent Development
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Major Businesses
Table 117. Sanofi Cancer Pain Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Sanofi Product
Table 119. Sanofi Recent Development
Table 120. WEX Pharmaceuticals Corporation Information
Table 121. WEX Pharmaceuticals Description and Major Businesses
Table 122. WEX Pharmaceuticals Cancer Pain Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. WEX Pharmaceuticals Product
Table 124. WEX Pharmaceuticals Recent Development
Table 125. Global Cancer Pain Therapeutics Sales Forecast by Regions (2021-2026) (K Units)
Table 126. Global Cancer Pain Therapeutics Sales Market Share Forecast by Regions (2021-2026)
Table 127. Global Cancer Pain Therapeutics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 128. Global Cancer Pain Therapeutics Revenue Market Share Forecast by Regions (2021-2026)
Table 129. North America: Cancer Pain Therapeutics Sales Forecast by Country (2021-2026) (K Units)
Table 130. North America: Cancer Pain Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Europe: Cancer Pain Therapeutics Sales Forecast by Country (2021-2026) (K Units)
Table 132. Europe: Cancer Pain Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Asia Pacific: Cancer Pain Therapeutics Sales Forecast by Region (2021-2026) (K Units)
Table 134. Asia Pacific: Cancer Pain Therapeutics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 135. Latin America: Cancer Pain Therapeutics Sales Forecast by Country (2021-2026) (K Units)
Table 136. Latin America: Cancer Pain Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Middle East and Africa: Cancer Pain Therapeutics Sales Forecast by Country (2021-2026) (K Units)
Table 138. Middle East and Africa: Cancer Pain Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Cancer Pain Therapeutics Players
Table 143. Cancer Pain Therapeutics Customers List
Table 144. Cancer Pain Therapeutics Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Pain Therapeutics Product Picture
Figure 2. Global Cancer Pain Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. Opioids Product Picture
Figure 4. Non-Steroidal Anti-Inflammatory Drugs Product Picture
Figure 5. Others Product Picture
Figure 6. Global Cancer Pain Therapeutics Sales Market Share by Application in 2020 & 2026
Figure 7. Paracetamol Treatment-Related Immunotherapy
Figure 8. Radiotherapy
Figure 9. Chemotherapy
Figure 10. Hormone Therapy
Figure 11. Cancer Pain Therapeutics Report Years Considered
Figure 12. Global Cancer Pain Therapeutics Market Size 2015-2026 (US$ Million)
Figure 13. Global Cancer Pain Therapeutics Sales 2015-2026 (K Units)
Figure 14. Global Cancer Pain Therapeutics Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Cancer Pain Therapeutics Sales Market Share by Region (2015-2020)
Figure 16. Global Cancer Pain Therapeutics Sales Market Share by Region in 2019
Figure 17. Global Cancer Pain Therapeutics Revenue Market Share by Region (2015-2020)
Figure 18. Global Cancer Pain Therapeutics Revenue Market Share by Region in 2019
Figure 19. Global Cancer Pain Therapeutics Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Cancer Pain Therapeutics Revenue in 2019
Figure 21. Cancer Pain Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Cancer Pain Therapeutics Sales Market Share by Type (2015-2020)
Figure 23. Global Cancer Pain Therapeutics Sales Market Share by Type in 2019
Figure 24. Global Cancer Pain Therapeutics Revenue Market Share by Type (2015-2020)
Figure 25. Global Cancer Pain Therapeutics Revenue Market Share by Type in 2019
Figure 26. Global Cancer Pain Therapeutics Market Share by Price Range (2015-2020)
Figure 27. Global Cancer Pain Therapeutics Sales Market Share by Application (2015-2020)
Figure 28. Global Cancer Pain Therapeutics Sales Market Share by Application in 2019
Figure 29. Global Cancer Pain Therapeutics Revenue Market Share by Application (2015-2020)
Figure 30. Global Cancer Pain Therapeutics Revenue Market Share by Application in 2019
Figure 31. North America Cancer Pain Therapeutics Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Cancer Pain Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Cancer Pain Therapeutics Sales Market Share by Country in 2019
Figure 34. North America Cancer Pain Therapeutics Revenue Market Share by Country in 2019
Figure 35. U.S. Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Cancer Pain Therapeutics Market Share by Type in 2019
Figure 40. North America Cancer Pain Therapeutics Market Share by Application in 2019
Figure 41. Europe Cancer Pain Therapeutics Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Cancer Pain Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Cancer Pain Therapeutics Sales Market Share by Country in 2019
Figure 44. Europe Cancer Pain Therapeutics Revenue Market Share by Country in 2019
Figure 45. Germany Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Cancer Pain Therapeutics Market Share by Type in 2019
Figure 56. Europe Cancer Pain Therapeutics Market Share by Application in 2019
Figure 57. Asia Pacific Cancer Pain Therapeutics Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Cancer Pain Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Cancer Pain Therapeutics Sales Market Share by Region in 2019
Figure 60. Asia Pacific Cancer Pain Therapeutics Revenue Market Share by Region in 2019
Figure 61. China Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Cancer Pain Therapeutics Market Share by Type in 2019
Figure 84. Asia Pacific Cancer Pain Therapeutics Market Share by Application in 2019
Figure 85. Latin America Cancer Pain Therapeutics Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Cancer Pain Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Cancer Pain Therapeutics Sales Market Share by Country in 2019
Figure 88. Latin America Cancer Pain Therapeutics Revenue Market Share by Country in 2019
Figure 89. Mexico Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Cancer Pain Therapeutics Market Share by Type in 2019
Figure 96. Latin America Cancer Pain Therapeutics Market Share by Application in 2019
Figure 97. Middle East and Africa Cancer Pain Therapeutics Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Cancer Pain Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Cancer Pain Therapeutics Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Cancer Pain Therapeutics Revenue Market Share by Country in 2019
Figure 101. Turkey Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Cancer Pain Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Cancer Pain Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Cancer Pain Therapeutics Market Share by Type in 2019
Figure 108. Middle East and Africa Cancer Pain Therapeutics Market Share by Application in 2019
Figure 109. North America Cancer Pain Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Cancer Pain Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Cancer Pain Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Cancer Pain Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Cancer Pain Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Cancer Pain Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Cancer Pain Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Cancer Pain Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Cancer Pain Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Cancer Pain Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
疼痛管理治療薬の世界市場（～2026年） Market Analysis and Insights: Global Pain Management Therapeutics Market The global Pain Management Therapeutics market size is projected to reach US$ 59160 million by 2026, from US$ 57740 million in 2020, at a CAGR of 2.3%% during 2021-2026. Global Pain Management Therapeutics Scope and Market Size…- 局所疼痛管理治療薬の世界市場（～2026年） Market Analysis and Insights: Global Topical Pain Management Therapeutics Market The global Topical Pain Management Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Topical Pain Management Therapeutics Scop…
- 慢性腰痛治療の世界市場（～2026年） Low back pain can be standardized into two categories, acute and chronic. Pain for less than three months can be classified as acute, while continued pain for more than three months is classified as chronic. Market Analysis and Insights: Global Chronic Low Back Pain Treatment Market The global Chron…
- 頭頸部がん治療薬/治療の世界市場（～2026年） Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private…
- 肺がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Therapeutics Market The global Lung Cancer Therapeutics market size is projected to reach US$ 15800 million by 2026, from US$ 14180 million in 2020, at a CAGR of 10.6%% during 2021-2026. Global Lung Cancer Therapeutics Scope and Market Size Lung Cance…